Xenova Group PLC -- Tariquidar Phase I Paediatric Study Data Presented at ASCO
June 07, 2004 02:15 ET
|
Xenova Group PLC
SLOUGH, U.K., June, 7 2004 (PRIMEZONE) -- Xenova Group plc (LSE:XEN) (Nasdaq:XNVA) announced today that the Paediatric Oncology Branch of the National Cancer Institute (NCI) in Bethesda, U.S.,...
Xenova and FDA reach agreement on SPA Phase III trial programme for TransMID -- Enrollment to Begin Immediately
May 11, 2004 04:35 ET
|
Xenova Group PLC
SLOUGH, U.K. May 11, 2004 (PRIMEZONE) -- Xenova Group plc (LSE:XEN) (Nasdaq:XNVA) announced today that it has reached agreement with the US Food and Drug Administration (FDA) under the Special...
Xenova Group plc First Quarter Results, 2004
May 06, 2004 02:57 ET
|
Xenova Group PLC
SLOUGH, U.K., May 6, 2004 (PRIMEZONE) -- Xenova Group plc (Nasdaq:XNVA) (LSE:XEN) today announced its results for the quarter ended 31 March 2004.
Year to Date Highlights
* Revenue recognised for...
Xenova Signs Lease Agreement with Genzyme
April 07, 2004 02:16 ET
|
Xenova Group PLC
SLOUGH, U.K., April 7, 2004 (PRIMEZONE) -- Xenova Group plc (LSE:XEN) (Nasdaq:XNVA) announced today that it has signed a 10 year agreement with Genzyme Limited ("Genzyme") leasing to them the vacant...
Xenova Group plc -- Preliminary Results for the Year Ended 31 December 2003
February 24, 2004 02:38 ET
|
Xenova Group PLC
SLOUGH, U.K., Feb. 24, 2004 (PRIMEZONE) -- Xenova Group plc (Nasdaq:XNVA) (LSE:XEN) today announced its results for the year ended 31 December 2003.
Highlights:
-- Acquisition of KS Biomedix...